Zhejiang Shenghua Biok Biology Co Ltd

SHG:600226 China Conglomerates
Market Cap
$2.44 Billion
CN¥17.91 Billion CNY
Market Cap Rank
#6186 Global
#914 in China
Share Price
CN¥6.02
Change (1 day)
+10.05%
52-Week Range
CN¥2.51 - CN¥6.25
All Time High
CN¥8.64
Categories
Companies in China Conglomerates
About

Zhejiang Hengtong Holding Co.,Ltd. develops, produces, and sells biological pesticides, veterinary drugs, and animal feed additive products in China and Internationally. The company offers electronic and lithium battery copper foil for use in integrated circuit boards, lithium battery electrodes, and other products, as well as amino acid products. It also engages in the cogeneration of heat and p… Read more

Zhejiang Shenghua Biok Biology Co Ltd (600226) - Net Assets

Latest net assets as of September 2025: CN¥3.61 Billion CNY

Based on the latest financial reports, Zhejiang Shenghua Biok Biology Co Ltd (600226) has net assets worth CN¥3.61 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.85 Billion) and total liabilities (CN¥1.24 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥3.61 Billion
% of Total Assets 74.46%
Annual Growth Rate 16.61%
5-Year Change 29.93%
10-Year Change 140.63%
Growth Volatility 82.42

Zhejiang Shenghua Biok Biology Co Ltd - Net Assets Trend (1997–2024)

This chart illustrates how Zhejiang Shenghua Biok Biology Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Zhejiang Shenghua Biok Biology Co Ltd (1997–2024)

The table below shows the annual net assets of Zhejiang Shenghua Biok Biology Co Ltd from 1997 to 2024.

Year Net Assets Change
2024-12-31 CN¥3.42 Billion -2.10%
2023-12-31 CN¥3.49 Billion +12.96%
2022-12-31 CN¥3.09 Billion +16.27%
2021-12-31 CN¥2.66 Billion +1.05%
2020-12-31 CN¥2.63 Billion -25.75%
2019-12-31 CN¥3.54 Billion -18.30%
2018-12-31 CN¥4.33 Billion +3.07%
2017-12-31 CN¥4.20 Billion +146.09%
2016-12-31 CN¥1.71 Billion +20.37%
2015-12-31 CN¥1.42 Billion -2.10%
2014-12-31 CN¥1.45 Billion +2.84%
2013-12-31 CN¥1.41 Billion -1.58%
2012-12-31 CN¥1.43 Billion +1.67%
2011-12-31 CN¥1.41 Billion +4.34%
2010-12-31 CN¥1.35 Billion +7.06%
2009-12-31 CN¥1.26 Billion +5.23%
2008-12-31 CN¥1.20 Billion +14.44%
2007-12-31 CN¥1.05 Billion +5.41%
2006-12-31 CN¥993.45 Million +5.04%
2005-12-31 CN¥945.80 Million +6.41%
2004-12-31 CN¥888.84 Million +4.40%
2003-12-31 CN¥851.39 Million +5.98%
2002-12-31 CN¥803.33 Million +68.69%
2001-12-31 CN¥476.22 Million +8.21%
2000-12-31 CN¥440.10 Million +10.15%
1999-12-31 CN¥399.54 Million +417.65%
1998-12-31 CN¥77.18 Million +43.34%
1997-12-31 CN¥53.85 Million --

Equity Component Analysis

This analysis shows how different components contribute to Zhejiang Shenghua Biok Biology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1675.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥194.82 Million 5.70%
Common Stock CN¥3.06 Billion 89.57%
Other Comprehensive Income CN¥311.34 Million 9.12%
Total Equity CN¥3.42 Billion 100.00%

Zhejiang Shenghua Biok Biology Co Ltd Competitors by Market Cap

The table below lists competitors of Zhejiang Shenghua Biok Biology Co Ltd ranked by their market capitalization.

Company Market Cap
Shandong Xinchao Energy Co Ltd
SHG:600777
 		$1.35 Billion
SNGN Romgaz SA
LSE:SNGR
 		$1.35 Billion
Pandox AB Series B
LSE:0R8U
 		$1.35 Billion
Leggett & Platt Incorporated
NYSE:LEG
 		$1.35 Billion
Infinera Corporation
NASDAQ:INFN
 		$1.35 Billion
Jilin Chemical Fibre Co Ltd
SHE:000420
 		$1.35 Billion
MaxLinear Inc
NASDAQ:MXL
 		$1.35 Billion
Daetwyler Holding AG
LSE:0QNJ
 		$1.35 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhejiang Shenghua Biok Biology Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 3,259,189,338 to 3,415,285,811, a change of 156,096,473 (4.8%).
  • Net income of 189,453,476 contributed positively to equity growth.
  • Dividend payments of 13,284,298 reduced retained earnings.
  • Other comprehensive income increased equity by 35,918,017.
  • Other factors decreased equity by 55,990,722.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥189.45 Million +5.55%
Dividends Paid CN¥13.28 Million -0.39%
Other Comprehensive Income CN¥35.92 Million +1.05%
Other Changes CN¥-55.99 Million -1.64%
Total Change CN¥- 4.79%

Book Value vs Market Value Analysis

This analysis compares Zhejiang Shenghua Biok Biology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.57x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 139.86x to 5.57x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1997-12-31 CN¥0.04 CN¥6.02 x
1998-12-31 CN¥0.06 CN¥6.02 x
1999-12-31 CN¥0.32 CN¥6.02 x
2000-12-31 CN¥0.35 CN¥6.02 x
2001-12-31 CN¥0.38 CN¥6.02 x
2002-12-31 CN¥0.62 CN¥6.02 x
2003-12-31 CN¥0.66 CN¥6.02 x
2004-12-31 CN¥0.68 CN¥6.02 x
2005-12-31 CN¥0.73 CN¥6.02 x
2006-12-31 CN¥0.76 CN¥6.02 x
2007-12-31 CN¥0.80 CN¥6.02 x
2008-12-31 CN¥0.88 CN¥6.02 x
2009-12-31 CN¥0.94 CN¥6.02 x
2010-12-31 CN¥1.02 CN¥6.02 x
2011-12-31 CN¥1.06 CN¥6.02 x
2012-12-31 CN¥1.03 CN¥6.02 x
2013-12-31 CN¥1.11 CN¥6.02 x
2014-12-31 CN¥0.76 CN¥6.02 x
2015-12-31 CN¥0.72 CN¥6.02 x
2016-12-31 CN¥0.83 CN¥6.02 x
2017-12-31 CN¥1.45 CN¥6.02 x
2018-12-31 CN¥1.53 CN¥6.02 x
2019-12-31 CN¥1.13 CN¥6.02 x
2020-12-31 CN¥0.84 CN¥6.02 x
2021-12-31 CN¥0.90 CN¥6.02 x
2022-12-31 CN¥1.05 CN¥6.02 x
2023-12-31 CN¥1.18 CN¥6.02 x
2024-12-31 CN¥1.08 CN¥6.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhejiang Shenghua Biok Biology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 5.55%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 14.20%
  • • Asset Turnover: 0.30x
  • • Equity Multiplier: 1.32x
  • Recent ROE (5.55%) is below the historical average (7.94%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 25.75% 23.13% 0.44x 2.54x CN¥8.48 Million
1998 46.10% 30.82% 0.72x 2.09x CN¥27.86 Million
1999 8.59% 29.48% 0.27x 1.09x CN¥-5.64 Million
2000 13.14% 28.26% 0.37x 1.25x CN¥13.81 Million
2001 14.67% 18.59% 0.59x 1.35x CN¥22.19 Million
2002 6.50% 13.03% 0.39x 1.28x CN¥-27.10 Million
2003 6.06% 8.30% 0.54x 1.35x CN¥-32.57 Million
2004 7.06% 5.97% 0.76x 1.56x CN¥-25.06 Million
2005 8.11% 5.03% 0.85x 1.89x CN¥-17.14 Million
2006 7.10% 4.22% 0.90x 1.87x CN¥-27.64 Million
2007 7.86% 3.89% 0.99x 2.03x CN¥-21.52 Million
2008 11.58% 4.66% 1.29x 1.92x CN¥17.36 Million
2009 12.08% 9.39% 0.72x 1.78x CN¥24.49 Million
2010 10.76% 7.80% 0.79x 1.75x CN¥9.71 Million
2011 7.28% 5.41% 0.76x 1.76x CN¥-35.65 Million
2012 2.52% 2.05% 0.75x 1.65x CN¥-100.70 Million
2013 2.05% 1.73% 0.69x 1.72x CN¥-107.74 Million
2014 5.82% 6.17% 0.58x 1.64x CN¥-59.66 Million
2015 9.93% 13.85% 0.45x 1.59x CN¥-1.03 Million
2016 13.85% 45.94% 0.15x 1.98x CN¥65.55 Million
2017 6.21% 19.83% 0.24x 1.30x CN¥-159.23 Million
2018 3.27% 14.43% 0.19x 1.17x CN¥-292.02 Million
2019 -18.50% -81.45% 0.19x 1.17x CN¥-1.01 Billion
2020 -35.80% -169.58% 0.18x 1.16x CN¥-1.21 Billion
2021 14.10% 55.05% 0.23x 1.11x CN¥109.08 Million
2022 15.62% 80.13% 0.18x 1.07x CN¥173.64 Million
2023 5.09% 25.58% 0.15x 1.32x CN¥-160.16 Million
2024 5.55% 14.20% 0.30x 1.32x CN¥-152.08 Million

Industry Comparison

This section compares Zhejiang Shenghua Biok Biology Co Ltd's net assets metrics with peer companies in the Conglomerates industry.

Industry Context

  • Industry: Conglomerates
  • Average net assets among peers: $978,124,373
  • Average return on equity (ROE) among peers: 8.21%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Zhejiang Shenghua Biok Biology Co Ltd (600226) CN¥3.61 Billion 25.75% 0.34x $1.35 Billion
China Baoan Group Co Ltd (000009) $1.27 Billion 1.07% 2.24x $1.86 Billion
Yunding Technology Co Ltd (000409) $941.98 Million 8.55% 0.27x $527.49 Million
Create Technology & Science Co Ltd (000551) $251.29 Million 12.94% 2.35x $557.14 Million
Sundiro Holding Co Ltd (000571) $1.77 Billion 7.65% 0.23x $606.69 Million
Guangdong Ganhua Science & Industry Co Ltd (000576) $701.02 Million 10.07% 0.54x $356.12 Million
Macrolink Real Estate Co Ltd (000620) $143.94 Million 0.00% 3.19x $1.86 Billion
Tianjin Economic-technological Development Area Co Ltd (000652) $571.94 Million 29.23% 0.30x $544.91 Million
CHTC Helon Co Ltd (000677) $529.22 Million 4.03% 1.82x $434.09 Million
Gansu Yatai Industrial Development Co Ltd (000691) $673.22 Million 5.50% 0.58x $290.70 Million
Hunan Fazhan Industrial Co Ltd (000722) $2.92 Billion 3.04% 0.07x $393.69 Million